Sanford
Fargo, North Dakota, 58102, United States
NCT Number: NCT03735797
Descriptive study of acute leukemia patients. Bone marrow aspirate or peripheral blood samples will be analyzed by next-generation sequencing for novel gene signatures and variations in transcriptional and epigenetic regulatory elements such as ARID5B and SALL4 variants.
This study is active but is not currently recruiting participants.
1 month–30 year
All sexes
Observational
Fargo, North Dakota, 58102, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Collection of specimen samples only
Time frame: 5 years
Correlation of our experimentally validated Arid5b dependent transcriptional signature with primary patient samples measured by patient ARID5B expression and polymorphisms.
Sanford Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05589896
Acute Biphenotypic Leukemia, Acute Leukemia
Duarte, California, United States
View Trial DetailsNCT05428176
Acute Leukemia, Acute Lymphoblastic Leukemia
Duarte, California, United States
View Trial DetailsNCT04013685
Acute Leukemia, Acute Lymphoid Leukemia
Duarte, California, United States
View Trial DetailsNCT05088356
Acute Leukemia, Advanced Hematologic Malignancies
Stanford, California, United States
View Trial Details